Search
for
Sort by
Research 541–570 of 725
- Immunology of alopecia areata
- Revolutionizing psoriasis care: Microneedle innovations in treatment and diagnosis
- The Role of Extracellular Vesicles in the Development and Treatment of Psoriasis: Narrative Review
- Gut microbiota-derived metabolites in keloid and hypertrophic scarring
- Clinical Applications of Extracellular Vesicles: Promises and Pitfalls
- The Effects of Androgens on T Cells: Clues to Female Predominance in Autoimmune Liver Diseases?
- PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- A review on the chemical constituents and pharmacological efficacies of Lindera aggregata (Sims) Kosterm
- Exploring the Role of Gut Microbiota in Patients with Alopecia Areata
- Hair Follicle-Related MicroRNA-34a Serum Expression and rs2666433A/G Variant in Patients with Alopecia: A Cross-Sectional Analysis
- Interleukin gene polymorphisms and alopecia areata: A systematic review and meta-analysis
- Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress
- Adipose-derived stem cells applied in skin diseases, wound healing and skin defects: a review
- Evaluating the Causal Relationship Between Human Blood Metabolites and the Susceptibility to Alopecia Areata
- The Immunological Intersection of Psoriasis and Autoimmune Diseases: Shared Pathways and Clinical Implications
- Immunopathogenesis and Experimental Models of Alopecia Areata: From Mechanistic Insights to Translational Platforms
- The brain–gut–skin axis in inflammatory and disfiguring skin diseases: mechanistic insights, clinical correlations, and therapeutic strategies
- Enhancing Cancer Therapy with Hyperthermia: Synergistic Effects with Natural Compounds and Conventional Treatments
- Nanomaterials applied in wound healing: mechanisms, limitations and perspectives
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Diseases of the Canine Prostate Gland
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- Microneedle-Mediated Transdermal Drug Delivery for the Treatment of Multiple Skin Diseases
- Pathomechanisms of immune-mediated alopecia
- Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications
- Microbial allies in skin trauma recovery: from immune modulation to engineered probiotic therapeutics
- Is there a ‘gut–brain–skin axis’?
- Endogenous Retinoids in the Pathogenesis of Alopecia Areata
- Therapeutics for COVID-19 and post COVID-19 complications: An update